Literature DB >> 24661982

Modulation of behavior by the histaminergic system: lessons from H(1)R-and H(2)R-deficient mice.

Erich H Schneider1, Detlef Neumann2, Roland Seifert2.   

Abstract

Besides acting in the immune system, histamine is also a neurotransmitter in the central nervous system. The H1R causes central side effects, e.g. of first generation antihistamines, antidepressants or antipsychotics and represents the component of the central histaminergic system most extensively studied in behavior experiments with knock-out mice. Central effects of H2R are similar, but only few behavioral results from knockout models are available. We summarize the behavior phenotype of H1R- and H2R-deficient mice, revealing histaminergic modulation of behaviors like locomotor activity, cognition, emotional states, arousal, sleep and wakefulness, circadian rhythm, pain perception, food intake and energy consumption, respiration and susceptibility to seizures. Knock-out models demonstrate several central effects of H1R and H2R that are not clinically and therapeutically exploited to date. We critically discuss problems and pitfalls of both the knock-out mouse technique and the pharmacological approach with receptor-selective ligands. The behavioral characterization of Hrh1(-/-)- and Hrh2(-/-)-mice is crucial, because many pharmacological agents lack the required selectivity to unequivocally address the functions of a single histamine receptor subtype.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavior; Brain; Circadian rhythm; Food intake; Histamine receptor; Knockout mouse; Learning; Memory; Pain; Respiration; Seizures; Sleep

Mesh:

Substances:

Year:  2014        PMID: 24661982     DOI: 10.1016/j.neubiorev.2014.03.009

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  15 in total

1.  Histamine H4-receptor expression in the brain?

Authors:  Erich H Schneider; Detlef Neumann; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-26       Impact factor: 3.000

Review 2.  Brain histamine modulates recognition memory: possible implications in major cognitive disorders.

Authors:  Gustavo Provensi; Alessia Costa; Ivan Izquierdo; Patrizio Blandina; Maria Beatrice Passani
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

Review 3.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Glutamate Is a Wake-Active Neurotransmitter in Drosophila melanogaster.

Authors:  John E Zimmerman; May T Chan; Olivia T Lenz; Brendan T Keenan; Greg Maislin; Allan I Pack
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

Review 5.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 6.  Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System.

Authors:  Erich H Schneider; Roland Seifert
Journal:  Handb Exp Pharmacol       Date:  2017

7.  Chemical Probes for Histamine Receptor Subtypes.

Authors:  Markus Falkenstein; Milica Elek; Holger Stark
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 8.  Efficacy and Safety of Non-brain Penetrating H1-Antihistamines for the Treatment of Allergic Diseases.

Authors:  Kazuhiko Yanai; Takeo Yoshikawa; Martin K Church
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 9.  The histidine decarboxylase model of tic pathophysiology: a new focus on the histamine H3 receptor.

Authors:  Christopher Pittenger
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

10.  Generation and identification of endothelial-specific Hrh2 knockout mice.

Authors:  Rui Meng; Wen-Ke Cai; Wen-Mang Xu; Qiang Feng; Ping Wang; Yan-Hua Huang; Yu-Xin Fan; Tao Zhou; Qin Yang; Zhi-Ran Li; Gong-Hao He
Journal:  Transgenic Res       Date:  2021-03-30       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.